Alibaba Health Information Technology Ltd
OTC:ALBHF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/EBIT
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBIT returns to its 3-Year Average (48.8), the stock would be worth $0.9 (52% upside from current price).
| Scenario | EV/EBIT Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 32.1 | $0.59 |
0%
|
| 3-Year Average | 48.8 | $0.9 |
+52%
|
| 5-Year Average | 47.3 | $0.87 |
+48%
|
| Industry Average | 14.7 | $0.27 |
-54%
|
| Country Average | 10.3 | $0.19 |
-68%
|
Forward EV/EBIT
Today’s price vs future ebit
| Today's Enterprise Value | EBIT | Forward EV/EBIT | ||
|---|---|---|---|---|
|
$83.7B
|
/ |
Oct 2025
¥1.7B
|
= |
|
|
$83.7B
|
/ |
Mar 2026
¥2.4B
|
= |
|
|
$83.7B
|
/ |
Mar 2027
¥2.9B
|
= |
|
|
$83.7B
|
/ |
Mar 2028
¥3.5B
|
= |
|
|
$83.7B
|
/ |
Mar 2029
¥4.2B
|
= |
|
Forward EV/EBIT shows whether today’s EV/EBIT still looks high or low once future ebit are taken into account.
Peer Comparison
| Market Cap | EV/EBIT | P/E | ||||
|---|---|---|---|---|---|---|
| HK |
A
|
Alibaba Health Information Technology Ltd
OTC:ALBHF
|
73.5B USD | 32.1 | 33.5 | |
| US |
|
Amazon.com Inc
NASDAQ:AMZN
|
2.7T USD | 34.6 | 36.3 | |
| ZA |
N
|
Naspers Ltd
JSE:NPN
|
703.6B ZAR | 159.8 | 7.5 | |
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
314.2B USD | 24.4 | 24 | |
| CN |
|
PDD Holdings Inc
NASDAQ:PDD
|
138.8B USD | 5.6 | 9.6 | |
| NL |
|
Prosus NV
AEX:PRX
|
98.8B EUR | 490.5 | 8.6 | |
| UY |
|
MercadoLibre Inc
BMV:MELIN
|
1.6T MXN | 28.2 | 46.1 | |
| AR |
|
Mercadolibre Inc
NASDAQ:MELI
|
91.3B USD | 28.3 | 46.3 | |
| US |
D
|
DoorDash Inc
NASDAQ:DASH
|
76.9B USD | 101.8 | 82.4 | |
| CN |
|
Meituan
HKEX:3690
|
507.9B HKD | -12.8 | -19.3 | |
| CN |
|
JD.Com Inc
HKEX:9618
|
377.4B HKD | 48.8 | 16.9 |
Market Distribution
| Min | 0 |
| 30th Percentile | 5.4 |
| Median | 10.3 |
| 70th Percentile | 15.8 |
| Max | 9 749.3 |
Other Multiples
Alibaba Health Information Technology Ltd
Glance View
Alibaba Health Information Technology Ltd., often referred to as Alibaba Health, is a pioneering force in the rapidly evolving realm of digital healthcare. As the healthcare arm of the Alibaba conglomerate, it capitalizes on the group's formidable tech expertise and e-commerce prowess to streamline health services. Its operations stretch across several domains, from pharmaceutical retail to medical services. One of the company's key strengths lies in its online pharmacy platform. Partnering with various pharmaceutical brands, Alibaba Health provides an extensive digital marketplace for medications, health supplements, and medical devices. This platform not only simplifies access for consumers but also integrates data analytics to manage supply chains efficiently, ensuring timely availability of products. Beyond its e-commerce foundation, Alibaba Health is also cultivating a robust digital health ecosystem. It offers telemedicine services where users can consult healthcare professionals via online platforms, a feature that gained significant traction during pandemic-related lockdowns. Moreover, the company dives deep into health management technologies, utilizing artificial intelligence to develop personalized health plans and digital tools for patient monitoring. By harnessing big data, Alibaba Health assists in forming public health decisions and improving patient outcomes. Revenues stream from not just product sales, but also subscription fees and partnerships with health providers and governments alike, positioning the company as a pivotal player in China's push towards a more integrated and efficient healthcare system.